Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer. (Q39354188)
Jump to navigation
Jump to search
scientific article published on 6 June 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer. |
scientific article published on 6 June 2017 |
Statements
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer (English)
Solange Peters
D Ross Camidge
Alice T Shaw
Shirish Gadgeel
Jin S Ahn
Dong-Wan Kim
Sai-Hong I Ou
Maurice Pérol
Ali Zeaiter
Emmanuel Mitry
Sophie Golding
Bogdana Balas
Johannes Noe
Peter N Morcos
ALEX Trial Investigators